Dr Phyllis E Miller, MD | |
1751 Gunbarrel Rd, Chattanooga, TN 37421-7177 | |
(423) 697-1857 | |
(423) 697-7564 |
Full Name | Dr Phyllis E Miller |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 1751 Gunbarrel Rd, Chattanooga, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528058906 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207VG0400X | Obstetrics & Gynecology - Gynecology | MD0000007890 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Phyllis E Miller, MD 4843 Hixson Pike, Hixson, TN 37343-4478 Ph: (423) 870-3700 | Dr Phyllis E Miller, MD 1751 Gunbarrel Rd, Chattanooga, TN 37421-7177 Ph: (423) 697-1857 |
News Archive
The mutation occurs in the androgen-synthesizing enzyme 3βHSD1 in castration-resistant prostate cancer (CRPC), according to research published online today in Cell. This mutation enables the tumor to make its own supply of androgens, a hormone that fuels the growth of the prostate cancer.
AMRI announced today that a third compound being developed under its license and research agreement with Bristol-Myers Squibb Company will proceed into preclinical development. AMRI will receive a $750,000 payment from Bristol-Myers Squibb for the completion of this milestone, marking the fifth milestone payment in the ongoing research collaboration between the two companies.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, will be presented during the 22nd Annual Symposium of EORTC-NCI-AACR being held November 16-19, 2010 in Berlin, Germany.
Patient Recruiters International, Inc. (PRI), a leading provider of direct patient access solutions for patient recruitment, announced today the launch of OnSite.
Promethera Biosciences SA, a world-leading cell therapy and regenerative medicine company targeting liver diseases, today announced the presentation of new preclinical NASH-Fibrosis data from its proprietary HepaStem program, demonstrating a beneficial effect of HepaStem in a nonalcoholic steatohepatitis (NASH) mouse model and confirming Hepastem's unique and multifaceted mode of action.
› Verified 5 days ago
John Sindos Adams Sr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 929 Spring Creek Road, Suite 104, Chattanooga, TN 37412 Phone: 423-510-0250 Fax: 423-510-9524 | |
Dr. Alicia Renee Allen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1651 Gunbarrel Rd Ste 201, Chattanooga, TN 37421 Phone: 423-899-9133 Fax: 423-855-8176 | |
Dr. Charles Patrick Johnson, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1751 Gunbarrel Rd, Suite 101, Chattanooga, TN 37421 Phone: 423-778-8558 Fax: 423-778-8560 | |
Dr. William Joel Moss, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1755 Gunbarrel Rd, Suite 205, Chattanooga, TN 37421 Phone: 423-756-0863 Fax: 706-937-2377 | |
Mr. Gary A. Brunvoll, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7490 Ziegler Rd, Chattanooga, TN 37421 Phone: 423-648-6020 Fax: 423-648-6025 | |
Elizabeth Maria Bowers, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1751 Gunbarrel Road, Suite 100, Chattanooga, TN 37421 Phone: 423-778-9500 Fax: 423-778-8882 | |
Porche' Warren Adams, DO, MPH Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 935 Spring Creek Rd Ste 100, Chattanooga, TN 37412 Phone: 423-510-0250 Fax: 423-510-9524 |